Skip to main content
. 2022 Jun 3;41:101068. doi: 10.1016/j.ijcha.2022.101068

Fig. 1.

Fig. 1

View of the pathophysiological mechanism of coagulopathy in COVID-19 patients. First, the viral infections can injure host endothelial cells, then abnormal blood flow dynamics and uncontrolled platelet activation occurs.